Pregnancy outcome after rheumatologic methotrexate (MTX) treatment prior to or during early pregnancy: a prospective multicenter cohort study (Rheumatologic MTX treatment and pregnancy outcome)

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  ENTIS provides drug risk assessment for pregnant patients and/or physicians. Exposed pregnancies are documented and after the expected date of delivery, follow-up is conducted both using a structured questionnaire or phone interview.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown